Damning analysis found only one in five treatments was beneficial Related items from OnMedica Expensive cancer drugs have little impact on survival UK patients losing out in access to cancer drugs Cancer drug access in England is a ‘debacle’ MPs slam government for its poor management of Cancer Drugs Fund 75% of reappraised CDF drugs approved for NHS |
No comments:
Post a Comment